US: 1.917.963.8646 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Asia-Pacific Phenylketonuria (PKU) Market and Forecast 2020-2026
- TBI828915
- October 07, 2020
- Global
- 132 pages
- IFF Market Research
Market Analysis and Insights: Asia-Pacific Phenylketonuria (PKU) Market
In 2019, the Asia-Pacific Phenylketonuria (PKU) market size was US$ 115.74 million and it is expected to reach US$ 180.01 million by the end of 2026, with a CAGR of 6.08% during 2020-2026.
Asia-Pacific Phenylketonuria (PKU) Scope and Segment
Phenylketonuria (PKU) market is segmented by company, region (country), by type, and by application. Players, stakeholders, and other participants in the Asia-Pacific Phenylketonuria (PKU) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by type and by application for the period 2015-2026.
By Company
- Biomarin
- Mead Johnson
- Abbott
- Nutricia
- Dr. Schär
- Vitaflo
- Cambrooke
- PKU Perspectives
- Firstplay Dietary
Segment by Type
- Medications
- Supplements
- Other
Segment by Application
Table of Contents
Chapter 1. Preface
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
1.3.3. Level 1: Primary Research
1.3.4. Level 2: Secondary Research
1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
Chapter 2. Executive Summary
2.1. Global Asia-Pacific Asia-Pacific Phenylketonuria (PKU) 2019-2029 (USD Billion)
2.2. Global Asia-Pacific Asia-Pacific Phenylketonuria (PKU): Market Snapshot
Chapter 3. Global Asia-Pacific Asia-Pacific Phenylketonuria (PKU) - Industry Analysis
| read more...